Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) (Q34067456)

30 July 2017

Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) (English)

1 reference

30 July 2017

1 reference

botulinum toxin type A

1 reference

1 reference

1

Joseph Jankovic

1 reference

30 July 2017

2

Charles H Adler

1 reference

30 July 2017

4

Cynthia Comella

1 reference

30 July 2017

P David Charles

3

1 reference

30 July 2017

Mark Stacy

5

1 reference

30 July 2017

Marc Schwartz

6

1 reference

30 July 2017

Susan M Sutch

7

1 reference

30 July 2017

Mitchell F Brin

8

1 reference

30 July 2017

Spyridon Papapetropoulos

9

1 reference

30 July 2017

4 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

140

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2377-11-140

30 July 2017

0 references

cites work

Flu-like symptoms following botulinum toxin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Cervical dystonia: unresolved issues and future challenges

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Epidemiology, clinical presentation, and diagnosis of cervical dystonia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Prevalence of cervical dystonia and spasmodic torticollis in the United States general population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Longitudinal assessment of the dose consistency of botulinum toxin type A (BOTOX) for cervical dystonia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Botulinum toxin in clinical practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

What are the determinants of quality of life in people with cervical dystonia?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Spasmodic torticollis--review of 220 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Cervical dystonia: clinical findings and associated movement disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Idiopathic cervical dystonia: clinical characteristics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

Impact of cervical dystonia on quality of life.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Quetiapine improves involuntary movements after cerebellar stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Long-term effect of botulinum toxin on impairment and functional health in cervical dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2377-11-140

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3220636

28 October 2018

Treatment of dystonia

1 reference

12 December 2020

Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance

1 reference

12 December 2020

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

1 reference

12 December 2020

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

1 reference

12 December 2020

Terminology for preparations of botulinum neurotoxins: what a difference a name makes

1 reference

12 December 2020

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

1 reference

12 December 2020

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2377-11-140

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference